Search | TVST | ARVO Journals

Showing 1 – 20 of 27

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Inflammatory Mediators in the Pathophysiology of Diabetic Retinopathy (INSPIRE): Correlation of Inflammatory Markers in Ocular Samples and Serum.

Archana Appukuttan Nair; John Fitzpatrick; Sarah Al-Awamlh; Jinsong Sheng; Kurt Scavelli; Paul Mallory; Sapna Gangaputra; Stephen Jae Kim

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3600 – A0055.

ARVO Annual Meeting Abstract June 2022

Cytokine Profiles of Normal Eyes in the INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy (INSPIRE) Study

John Carey Fitzpatrick; Archana Nair; Sarah Al-Awamlh; Kurt Scavelli; Paul Mallory; Jinsong Sheng; Sapna Gangaputra; Stephen Jae Kim

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2368 – A0052.

ARVO Annual Meeting Abstract June 2021

Real World Safety Profile of Fluocinolone Acetonide 0.18mg Injectable intravitreal Implant (FAi) in Chronic Uveitis

Hans Andrews; Saif Hamdan; Sapna Gangaputra; Stephen J Kim

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1430.

ARVO Annual Meeting Abstract June 2020

Efficacy of Avastin Step-Therapy for Age-Related Macular Degeneration

Jonathan Siktberg; Stephen J Kim; Shriji Patel

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4197.

ARVO Annual Meeting Abstract July 2019

Ophthalmic Implications of Immune Checkpoint Inhibitors: External Manifestations

Heather Tamez; Reid Longmuir; Christine Shieh; Stephen J Kim; Sapna Gangaputra

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):3534.

ARVO Annual Meeting Abstract July 2018

Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study – Five-Year Findings

Thomas Mendel; Karen M Joos; Jeffrey Kammer; Rachel W Kuchtey; Edward Cherney; Stephen J Kim

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4428.

ARVO Annual Meeting Abstract September 2016

Eight Week Maintenance Dosing of Intravitreal Bevacizumab for Neovacular Age-Related Macular Degeneration

Tomas A Moreno; Shriji Patel; Stephen J Kim

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):550.

ARVO Annual Meeting Abstract September 2016

Five-Year Functional Outcomes after Epiretinal Membrane Surgery: A Prospective, Controlled Study

Gowtham Jonna; Ian A. Thompson; Stephen J Kim

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1095.

ARVO Annual Meeting Abstract June 2015

Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study 24-Month Findings

Shriji Patel; Rohan Shah; Joshua Noren Carlson; Jeffrey Kammer; Rachel W Kuchtey; Karen M Joos; Edward F Cherney; Stephen J Kim

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4329.

Perspective October 2014

Novel Approaches for Retinal Drug and Gene Delivery

PDF

Stephen J. Kim
TAGS: anti-inflammatory agents, non-steroidal, drug delivery systems, gene therapy, genes, retinal diseases, hydrogels, animal model, intravitreal injections
Trans. Vis. Sci. Tech.. 2014; 3(5):7. https://doi.org/10.1167/tvst.3.5.7

Retina March 2014

The Safety, Pharmacokinetics, and Efficacy of Intraocular Celecoxib

PDF

Stephen J. Kim; Hassanain Toma; Rohan Shah; Uday B. Kompella; Sunil K. Vooturi; Jinsong Sheng
TAGS: celecoxib, pharmacokinetics, eye, electroretinography, uveitis, safety
Invest. Ophthalmol. Vis. Sci.. 2014; 55(3):1409-1418. https://doi.org/10.1167/iovs.13-13667

Retina August 2012

Increased Prostaglandin E2 (PGE 2 ) Levels in Proliferative Diabetic Retinopathy, and Correlation with VEGF and Inflammatory Cytokines

PDF

Scott D. Schoenberger; Stephen J. Kim; Jinsong Sheng; Kasra A. Rezaei; Maziar Lalezary; Edward Cherney
TAGS: cytokine, diabetic retinopathy, dinoprostone, proliferative diabetic retinopathy, prostaglandins, vascular endothelial growth factor a, eye, vitreous body
Invest. Ophthalmol. Vis. Sci.. 2012; 53(9):5906-5911. https://doi.org/10.1167/iovs.12-10410

ARVO Annual Meeting Abstract March 2012

The Value of Routine Preoperative Medical Testing for Vitreoretinal Surgery

Ajay Shalwala; Stephen J. Kim

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3750.

ARVO Annual Meeting Abstract March 2012

Three month results of the Prospective Retinal and Optic nerve Vitrectomy Evaluation (PROVE) study: a controlled clinical trial

Scott D. Schoenberger; Maziar Lalezary; Stephen J. Kim; Jeffrey A. Kammer; Rachel W. Kuchtey; Karen Joos; Franco M. Recchia; Edward F. Cherney

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3788.

ARVO Annual Meeting Abstract March 2012

Changes in Ocular Flora in Eyes Exposed to Macrolide or Fluoroquinolone Ophthalmic Antibiotics: A Prospective, Controlled, Longitudinal Study

Sarita B. Dave; Hassanain Toma; Stephen J. Kim

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):4181.

ARVO Annual Meeting Abstract March 2012

Antibacterial Properties of 2% Lidocaine on Staphylococcus Aureus, Staphylococcus Epidermidis, and Streptococcus Viridans and Reduced Rate of Post-injection Endophthalmitis

Stephen J. Kim; Aaron Tustin; Amy Chomsky; G. Baker Hubbard, III; Jinsong Sheng

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1691.

ARVO Annual Meeting Abstract March 2012

Incidence and Risk Factors for Chronic Uveitis Following Cataract Surgery

Mazeyar Saboori; Chirag R. Patel; Stephen J. Kim; Amy Chomsky

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):2289.

ARVO Annual Meeting Abstract March 2012

Retinal Toxicity of Polyethylene Glycol (PEG)-400

Kasra Attaran-Rezaei; Toma Hassanian; Stephen J. Kim

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5398.

ARVO Annual Meeting Abstract April 2011

Incidence and Risk Factors for Chronic Uveitis Following Cataract Surgery

Chirag R. Patel; Stephen J. Kim

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4713.

ARVO Annual Meeting Abstract April 2011

Emergence of Multi-Antibiotic Resistance of Conjunctival Flora: A Prospective, Controlled, Longitudinal Study of Patients Undergoing Intravitreal Injections

Sarita B. Dave; Stephen J. Kim; Hassanain Toma

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):5606.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Inflammatory Mediators in the Pathophysiology of Diabetic Retinopathy (INSPIRE): Correlation of Inflammatory Markers in Ocular Samples and Serum.

Cytokine Profiles of Normal Eyes in the INflammatory MediatorS in the PathophysIology of Diabetic REtinopathy (INSPIRE) Study

Real World Safety Profile of Fluocinolone Acetonide 0.18mg Injectable intravitreal Implant (FAi) in Chronic Uveitis

Efficacy of Avastin Step-Therapy for Age-Related Macular Degeneration

Ophthalmic Implications of Immune Checkpoint Inhibitors: External Manifestations

Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study – Five-Year Findings

Eight Week Maintenance Dosing of Intravitreal Bevacizumab for Neovacular Age-Related Macular Degeneration

Five-Year Functional Outcomes after Epiretinal Membrane Surgery: A Prospective, Controlled Study

Prospective Retinal and Optic Nerve Vitrectomy Evaluation (PROVE) Study 24-Month Findings

Novel Approaches for Retinal Drug and Gene Delivery

The Safety, Pharmacokinetics, and Efficacy of Intraocular Celecoxib

Increased Prostaglandin E2 (PGE 2 ) Levels in Proliferative Diabetic Retinopathy, and Correlation with VEGF and Inflammatory Cytokines

The Value of Routine Preoperative Medical Testing for Vitreoretinal Surgery

Three month results of the Prospective Retinal and Optic nerve Vitrectomy Evaluation (PROVE) study: a controlled clinical trial

Changes in Ocular Flora in Eyes Exposed to Macrolide or Fluoroquinolone Ophthalmic Antibiotics: A Prospective, Controlled, Longitudinal Study

Antibacterial Properties of 2% Lidocaine on Staphylococcus Aureus, Staphylococcus Epidermidis, and Streptococcus Viridans and Reduced Rate of Post-injection Endophthalmitis

Incidence and Risk Factors for Chronic Uveitis Following Cataract Surgery

Retinal Toxicity of Polyethylene Glycol (PEG)-400

Incidence and Risk Factors for Chronic Uveitis Following Cataract Surgery

Emergence of Multi-Antibiotic Resistance of Conjunctival Flora: A Prospective, Controlled, Longitudinal Study of Patients Undergoing Intravitreal Injections

To View More...

You must be signed into an individual account to use this feature.